Atorvastatin in the secondary prevention of cardiovascular diseases

Clinical manifestations of the atherosclerotic process are leading causes of mortality, morbidity and disability in the adult population of the developed countries all over the world. Many years of research have established a clear relationship between the risk of cardiovascular disease and high cho...

Full description

Bibliographic Details
Main Author: N. A. Vaulin
Format: Article
Language:Russian
Published: Remedium Group LLC 2014-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/666
id doaj-1b128c074a82492bb42f0cb82a4ef93c
record_format Article
spelling doaj-1b128c074a82492bb42f0cb82a4ef93c2021-07-28T13:29:17ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902014-12-01011333710.21518/2079-701X-2014-11-33-37666Atorvastatin in the secondary prevention of cardiovascular diseasesN. A. Vaulin0City Hospital №29 named after N.E. BaumanClinical manifestations of the atherosclerotic process are leading causes of mortality, morbidity and disability in the adult population of the developed countries all over the world. Many years of research have established a clear relationship between the risk of cardiovascular disease and high cholesterol level. Numerous global epidemiological studies, such as, for example, the Framingham Heart Study [1] and INTERHEART [2], provided solid evidence confirming that statement. Moreover, randomized clinical trials of lipid-lowering interventions over the past 10-15 years demonstrate that greater cholesterol reduction is associated with a significant decrease in the risk of complications.https://www.med-sovet.pro/jour/article/view/666сердечно-сосудистые заболеванияпрофилактикастатиныаторвастатинcardiovascular diseasepreventionstatinsatorvastatin
collection DOAJ
language Russian
format Article
sources DOAJ
author N. A. Vaulin
spellingShingle N. A. Vaulin
Atorvastatin in the secondary prevention of cardiovascular diseases
Медицинский совет
сердечно-сосудистые заболевания
профилактика
статины
аторвастатин
cardiovascular disease
prevention
statins
atorvastatin
author_facet N. A. Vaulin
author_sort N. A. Vaulin
title Atorvastatin in the secondary prevention of cardiovascular diseases
title_short Atorvastatin in the secondary prevention of cardiovascular diseases
title_full Atorvastatin in the secondary prevention of cardiovascular diseases
title_fullStr Atorvastatin in the secondary prevention of cardiovascular diseases
title_full_unstemmed Atorvastatin in the secondary prevention of cardiovascular diseases
title_sort atorvastatin in the secondary prevention of cardiovascular diseases
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2014-12-01
description Clinical manifestations of the atherosclerotic process are leading causes of mortality, morbidity and disability in the adult population of the developed countries all over the world. Many years of research have established a clear relationship between the risk of cardiovascular disease and high cholesterol level. Numerous global epidemiological studies, such as, for example, the Framingham Heart Study [1] and INTERHEART [2], provided solid evidence confirming that statement. Moreover, randomized clinical trials of lipid-lowering interventions over the past 10-15 years demonstrate that greater cholesterol reduction is associated with a significant decrease in the risk of complications.
topic сердечно-сосудистые заболевания
профилактика
статины
аторвастатин
cardiovascular disease
prevention
statins
atorvastatin
url https://www.med-sovet.pro/jour/article/view/666
work_keys_str_mv AT navaulin atorvastatininthesecondarypreventionofcardiovasculardiseases
_version_ 1721274566907527168